Search Results

There are 10349 results for: content related to: Effect of Tyrosine Kinase Inhibition Using Imatinib on Normal Lymphohematopoietic Cells

  1. You have free access to this content
    Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1097–1108, Jan H. Beumer, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Brian F. Kiesel, Michelle A. Rudek and Raman Venkataramanan

    Version of Record online : 19 SEP 2015, DOI: 10.1111/bcp.12723

  2. You have free access to this content
    Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2787–2798, AM Filppula, J Laitila, PJ Neuvonen and JT Backman

    Version of Record online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01732.x

  3. Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9P2, September 2010, Pages: 77S–101S, Kamakshi V. Rao, Andrea Iannucci and Elias Jabbour

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.77S

  4. Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 157–163, Y Yamakawa, A Hamada, T Shuto, M Yuki, T Uchida, H Kai, T Kawaguchi and H Saito

    Version of Record online : 1 JUN 2011, DOI: 10.1038/clpt.2011.102

  5. Imatinib Mesylate, the First Molecularly Targeted Gene Suppressor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 10, October 2002, Pages: 1249–1265, Vanita K. Pindolia and Barbara J. Zarowitz

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.15.1249.33482

  6. You have free access to this content
    Modulation of Imatinib Cytotoxicity by Selenite in HCT116 Colorectal Cancer Cells

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 1, January 2015, Pages: 37–46, Amal Kamal Abdel-Aziz, Samar Saad Eldeen Azab, Samar Samir Youssef, Abeer Mostafa El-Sayed, Ebtehal El-Demerdash and Samia Shouman

    Version of Record online : 25 JUL 2014, DOI: 10.1111/bcpt.12281

  7. Therapy of Advanced-Stage and Resistant Chronic Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Devendra K. Hiwase, Timothy P. Hughes, Pages: 281–295, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch23

  8. You have free access to this content
    Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 75–85, Didier Renard, Thomas Bouillon, Ping Zhou, Gerard Flesch and Debbie Quinn

    Version of Record online : 1 JUN 2015, DOI: 10.1111/bcp.12584

  9. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  10. Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options

    Journal of Surgical Oncology

    Volume 104, Issue 8, 15 December 2011, Pages: 888–895, Megan V. Caram and Scott M. Schuetze

    Version of Record online : 8 NOV 2011, DOI: 10.1002/jso.21930

  11. A molecular mechanics model for imatinib and imatinib:kinase binding

    Journal of Computational Chemistry

    Volume 31, Issue 7, May 2010, Pages: 1550–1560, Alexey Aleksandrov and Thomas Simonson

    Version of Record online : 17 DEC 2009, DOI: 10.1002/jcc.21442

  12. Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 – a report from the population-based CAMELIA Registry

    European Journal of Haematology

    Volume 87, Issue 2, August 2011, Pages: 157–168, Edgar Faber, Jan Mužík, Vladimír Koza, Eva Demečková, Jaroslava Voglová, Ĺudmila Demitrovičová, Juraj Chudej, Imrich Markuljak, Eduard Cmunt, Tomáš Kozák, Elena Tóthová, Marie Jarošová, Ladislav Dušek and Karel Indrák

    Version of Record online : 15 JUL 2011, DOI: 10.1111/j.1600-0609.2011.01637.x

  13. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  14. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest

    Cell Biology International

    Volume 39, Issue 8, August 2015, Pages: 923–932, Mariko Morii, Yasunori Fukumoto, Sho Kubota, Noritaka Yamaguchi, Yuji Nakayama and Naoto Yamaguchi

    Version of Record online : 27 APR 2015, DOI: 10.1002/cbin.10460

  15. You have free access to this content
    Controversies in the management of gastrointestinal stromal tumors

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 216–227, Desmond Yip, John Zalcberg, Stephen Ackland, Andrew P Barbour, Jayesh Desai, Stephen Fox, Dusan Kotasek, Grant McArthur and B Mark Smithers

    Version of Record online : 27 MAR 2014, DOI: 10.1111/ajco.12187

  16. Carbamazepine–imatinib interaction in a child with chronic myeloid leukemia

    Pediatrics International

    Volume 56, Issue 4, August 2014, Pages: e33–e36, Kazuaki Taguchi, Masahiko Kouroki, Takafumi Ohmura, Hirofumi Jono, Fumio Endo and Hideyuki Saito

    Version of Record online : 24 SEP 2014, DOI: 10.1111/ped.12382

  17. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate

    Liver International

    Volume 32, Issue 6, July 2012, Pages: 1008–1017, Youngchul Kim, Maria I. Fiel, Efsevia Albanis, Hsin I. Chou, Weijia Zhang, Gregory Khitrov and Scott L. Friedman

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1478-3231.2012.02806.x

  18. Imatinib mesylate in children and adolescents with cancer

    Pediatric Blood & Cancer

    Volume 55, Issue 1, 15 July 2010, Pages: 18–25, Ronald D. Barr

    Version of Record online : 1 APR 2010, DOI: 10.1002/pbc.22484

  19. Tyrosine Kinase Inhibitors

    Targeting Protein Kinases for Cancer Therapy

    David J. Matthews, Mary E. Gerritsen, Pages: 435–525, 2010

    Published Online : 11 MAR 2010, DOI: 10.1002/9780470555293.ch8

  20. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer

    The Prostate

    Volume 75, Issue 9, June 15, 2015, Pages: 923–935, Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia and Sílvia Socorro

    Version of Record online : 18 MAR 2015, DOI: 10.1002/pros.22976